Atlas Trials

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT06830850 · RECRUITING

Trial details

NCT number
NCT06830850
Sponsor
Atridia Pty Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration Resistant Prostate Cancer
Start date
2025-06-15
Primary completion
2026-12-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.